AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (385.5 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review Article | Open Access

Subretinal fluid in rhegmatogenous retinal detachment: potential biomarkers and therapeutic targets for proliferative vitreoretinopathy

Yi-Shuang Mao1, Wei-Hong Yu1,2,3( )
Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China
Beijing Key Laboratory of Fundus Diseases Intelligent Diagnosis & Drug/Device Development and Translation, Beijing 100730, China
Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences, Beijing 100730, China
Show Author Information

Abstract

Rhegmatogenous retinal detachment (RRD) is a serious ocular condition marked by the separation of the neuroretina from the retinal pigment epithelium (RPE). The pathogenesis of RRD involves intricate molecular and cellular mechanisms, including inflammation, cell migration, and the activation of proliferative signaling pathways. One of the most challenging complications of RRD is proliferative vitreoretinopathy (PVR), which refers to the proliferation and contraction of fibrocellular membranes on the retinal surface and in the vitreous cavity. PVR is a major cause of surgical failure in RRD, as it can lead to recurrent retinal detachment and severe vision loss. However, the pathogenesis of PVR is not yet fully understood, and the treatment options are quite limited. Recent advances in analytical techniques have offered valuable insights into the molecular alterations present in the subretinal fluid (SRF) of patients with RRD. This review seeks to consolidate the current knowledge regarding the SRF profile in RRD and PVR, emphasizing potential biomarkers and therapeutic targets.

References

【1】
【1】
 
 
International Journal of Ophthalmology
Pages 175-180

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Mao Y-S, Yu W-H. Subretinal fluid in rhegmatogenous retinal detachment: potential biomarkers and therapeutic targets for proliferative vitreoretinopathy. International Journal of Ophthalmology, 2026, 19(1): 175-180. https://doi.org/10.18240/ijo.2026.01.21

1851

Views

60

Downloads

0

Crossref

0

Web of Science

0

Scopus

0

CSCD

Received: 14 July 2025
Accepted: 26 September 2025
Published: 18 January 2026
© 2026 International Journal of Ophthalmology Press

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).